Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

Yahoo FinanceNov 4 21:00

Express News | Benitec Biopharma Inc Files for Mixed Shelf of up to $125 Mln - SEC Filing

BreakingsNov 2 05:05

Benitec Started at Outperform by Oppenheimer on Gene Therapy Potential

Seeking AlphaOct 17 03:51

Oppenheimer Maintains Benitec Biopharma(BNTC.US) With Buy Rating, Maintains Target Price $35

Futu NewsOct 16 20:31 · Ratings

Oppenheimer Initiates Benitec Biopharma(BNTC.US) With Buy Rating, Announces Target Price $35

Futu NewsOct 16 04:31 · Ratings

Benitec Biopharma Reports Promising Results for BB-301 Trial

TipRanksOct 15 20:30